Biodesix vs Mdxhealth SA
Mdxhealth SA is the larger business, with $108m of revenue in fiscal 2025 against $88.5m for Biodesix (1.2 times as much). Biodesix grew faster (24.1% against 19.8%). Mdxhealth SA kept more of each dollar of sales as profit: a net margin of -31.1% against -39.8%.
| Latest fiscal year | BiodesixBDSX, 2025 | Mdxhealth SAMDXH, 2025 |
|---|---|---|
| Revenue | $88.5m | $108m |
| Revenue growth | 24.1% | 19.8% |
| Net income | −$35.3m | −$33.5m |
| Operating margin | -31.5% | -13.4% |
| Net margin | -39.8% | -31.1% |
| Return on equity | — | — |
| Free cash flow | −$23.5m | −$3.3m |
| Cash | $19.0m | $29.0m |
| Total debt | $50.0m | $76.2m |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 334 | — |
| Market value | $223m | $7.9m |
| Price vs our value range | — | — |
| Moat score | 12 (Weak) | — |
| Insider trades, 12 months | 6 buys, 20 sales | 1 buys, 0 sales |